Plain-English translation of NCT07820254 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study designed to understand how well patients with pulmonary fibrosis can inhale through different types of inhaler devices. Researchers want to measure your peak inspiratory flow rate—how fast you can breathe in—and how long each breath takes when using inhalers with medium and high resistance. This information will help doctors choose the most effective inhaler devices for patients like you.
People with pulmonary fibrosis often have difficulty breathing, and the type of inhaler device prescribed can make a big difference in how well medication reaches the lungs. By measuring how well patients with this condition can inhale through different devices, researchers hope to provide guidance on which inhalers work best for these patients.
You likely qualify if…
You likely don't qualify if…
You will visit Shanghai Pulmonary Hospital for a single session lasting 30 to 60 minutes. After receiving brief training on how to use the device, you'll perform four breathing tests total: two tests at a medium-resistance setting and two tests at a high-resistance setting, with a 2-minute rest between the different resistance levels. A portable device called the In-Check™ DIAL G16 will measure how fast you breathe in and how long each breath lasts. No medications are given, and there are no injections or invasive procedures involved.
AI-generated summary from trial data · Sep 18, 2026 · Not medical advice
China